| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.03M | 47.03M | 46.37M | 46.51M | 36.04M | 42.62M |
| Gross Profit | 24.59M | 24.59M | 2.07M | 3.82M | 2.94M | 2.49M |
| EBITDA | 1.40M | 1.40M | -4.09M | 5.77M | 4.51M | 7.18M |
| Net Income | -1.27M | -1.27M | -9.78M | -2.76M | -1.30M | -1.24M |
Balance Sheet | ||||||
| Total Assets | 73.77M | 73.77M | 83.86M | 93.39M | 85.07M | 87.03M |
| Cash, Cash Equivalents and Short-Term Investments | 2.71M | 2.71M | 5.83M | 8.05M | 15.96M | 12.37M |
| Total Debt | 39.90M | 39.90M | 46.17M | 41.70M | 29.83M | 37.07M |
| Total Liabilities | 57.58M | 57.58M | 66.20M | 65.98M | 57.07M | 57.31M |
| Stockholders Equity | 16.20M | 16.20M | 17.66M | 26.84M | 27.59M | 29.13M |
Cash Flow | ||||||
| Free Cash Flow | 3.75M | 3.75M | 164.00K | -25.00K | 8.76M | 3.44M |
| Operating Cash Flow | 3.82M | 3.82M | 441.00K | 420.00K | 9.32M | 3.79M |
| Investing Cash Flow | -345.00K | -345.00K | -263.00K | -445.00K | -920.00K | -433.00K |
| Financing Cash Flow | -6.73M | -6.73M | -1.16M | -5.38M | -4.82M | -7.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | AU$120.90M | 14.63 | 60.13% | 1.19% | 120.57% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | AU$169.20M | 775.00 | 0.15% | ― | -1.08% | ― | |
48 Neutral | AU$15.25M | -11.98 | -7.51% | ― | 1.42% | 86.97% | |
48 Neutral | AU$58.95M | -4.03 | -53.18% | ― | -13.91% | 53.37% | |
48 Neutral | AU$33.45M | -6.42 | 10.80% | 1.67% | -2.81% | -503.02% | |
41 Neutral | AU$27.52M | -4.04 | -126.76% | ― | -14.55% | 70.98% |
Academies Australasia Group Limited announced a change in the director’s interest, specifically regarding Dr. John Lewis Schlederer. The notice details the acquisition of 75,091 ordinary shares, reflecting a continued investment in the company. This change may indicate confidence in the company’s future prospects and could impact stakeholders’ perceptions of the company’s stability and growth potential.
Academies Australasia Group Limited announced a change in the director’s interest notice concerning Dr. John Lewis Schlederer. The change involved the acquisition of 26,804 ordinary shares, valued at $3,471.79, through indirect interests. This update is part of the company’s compliance with ASX listing rules and reflects the ongoing management of director interests within the organization.
At the 2025 Annual General Meeting, Academies Australasia Group Limited announced the outcomes of resolutions voted on by shareholders. The resolution for the adoption of the remuneration report was not carried, with a significant majority voting against it. However, the re-election of Ms. Gabriela Del Carmen Rodriguez Naranjo as a director was successfully carried, receiving unanimous support. These outcomes may influence the company’s governance and strategic direction, impacting stakeholders and potentially affecting its market positioning.
Academies Australasia Group Limited reported a challenging yet improved financial performance for FY25, with revenue growth of 1.5% and a significant turnaround in EBITDA from a negative $2.5 million in FY24 to $7.2 million. The company saw a notable increase in higher education revenue, particularly in Perth, while English language operations faced a decline. The acquisition of shares in CSF has made Academies Australasia the sole shareholder of all its colleges. The company is recognized for its excellence in English language education, winning several awards. Looking ahead, the company faces challenges due to new government restrictions on international student allocations, impacting eight of its colleges.
Academies Australasia Group Limited announced a change in the director’s interest, specifically regarding Dr. John Lewis Schlederer. The change involves the acquisition of 98,105 ordinary shares valued at $11,772.60, reflecting an adjustment in the director’s indirect interest in the company. This update is part of the company’s compliance with ASX listing rules and the Corporations Act, potentially impacting the company’s governance and stakeholder interests.
Academies Australasia Group Limited announced a change in the director’s interest notice concerning Dr. John Lewis Schlederer. The notice details the acquisition of 163,655 ordinary shares by indirect interest, valued at $20,781.62. This change reflects an adjustment in the director’s securities holdings, potentially impacting the company’s governance and stakeholder interests.
Academies Australasia Group Limited has announced its 117th Annual General Meeting to be held on 21 November 2025 in Sydney. The meeting will cover financial statements and the adoption of the Remuneration Report, which is advisory and could lead to a ‘spill resolution’ if significant opposition is encountered over two consecutive meetings.
Academies Australasia Group Limited announced a change in the director’s interest notice concerning Mr. Christopher Campbell. The notice details the acquisition of 192,855 ordinary shares by Mr. Campbell, increasing his direct holdings to 2,550,000 shares, while his indirect holdings remain at 19,350,000 shares. This change reflects the company’s ongoing governance and transparency practices, potentially impacting stakeholder perceptions and market confidence.
Academies Australasia Group Limited announced a change in the director’s interest, specifically for Mr. Christopher Campbell, involving the acquisition of 7,145 ordinary shares. This update reflects a minor adjustment in the director’s shareholding, potentially indicating confidence in the company’s future prospects, which may interest stakeholders monitoring the company’s governance and financial health.
Academies Australasia Group Limited announced a change in the director’s interest, with Mr. Christopher Campbell acquiring 200,000 ordinary shares, increasing his direct holdings to 2,350,000 shares. This change reflects a potential strengthening of internal leadership commitment and confidence in the company’s future prospects, which may positively influence stakeholder perceptions.
Academies Australasia Group Limited announced a change in the director’s interest, specifically regarding Mr. Christopher Campbell, who acquired an additional 70,000 ordinary shares. This change reflects an increase in his direct interest in the company, potentially signaling confidence in the company’s future prospects. Such changes in director’s interests can impact stakeholder perceptions and influence market dynamics.
Academies Australasia Group Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement confirms the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, detailing the roles and responsibilities of the board and management, and ensuring transparency and accountability in its operations.
Academies Australasia Group Limited has released its Corporate Governance Statement, aligning with the ASX Corporate Governance Principles and Recommendations. The statement highlights the company’s governance practices and acknowledges areas where full compliance with the recommendations was not feasible due to the company’s size. The board, consisting of experienced directors, is responsible for overseeing the company’s performance and implementing governance practices, supported by committees such as the Audit and Risk Committee and the Remuneration Committee.
Academies Australasia Group Limited has released its Annual Report for 2025, detailing the company’s financial performance and strategic initiatives. The report includes comprehensive financial statements and insights into the company’s governance and management structure. This release is significant for stakeholders as it provides transparency into the company’s operations and future direction, potentially impacting investor confidence and market positioning.